Lam Research clears fresh all-time high, shares extend semiconductor rally
22.06.2026 - 20:31:19 | ad-hoc-news.deBy Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-22, 20:25.
Lam Research (US5324571083) has set a new all-time high, with the shares recently touching 401.03 US dollars on NASDAQ as reported by Investing.com. This move comes in the wake of multiple analyst upgrades and higher price targets that lean on accelerating AI-related wafer fabrication demand.
What the new high signals
According to Investing.com, Lam Research stock reached an intraday record of 401.03 US dollars, giving the semiconductor equipment maker a market capitalization of around 493 billion US dollars and marking a 1-year gain of roughly 333.5 percent. Investing.com report on the record high The same analysis notes that Lam sits on the platform's "Most Overvalued" list versus its calculated fair value, highlighting the tension between momentum and valuation.
Data from StockAnalysis show Lam Research with trailing twelve-month revenue of about 21.68 billion US dollars, up 26.5 percent year-on-year, and net income of roughly 6.71 billion US dollars, up 44 percent over the period. StockAnalysis profile and key figures The site also reports a current price-to-earnings ratio near 73 and a forward P/E above 50, underlining how far the shares have run ahead of consensus earnings expectations.
Analyst upgrades underpin sentiment
Several large research houses have raised their targets for Lam Research in recent weeks, adding institutional support to the rally. Investing.com summarizes that Morgan Stanley upgraded the stock to Overweight from Equalweight and lifted its price target to 331 US dollars, citing stronger forecasts for 2027 driven by NAND systems demand. Investing.com summary of analyst actions The same article highlights that Cantor Fitzgerald raised its target to 425 US dollars, pointing to AI-related advanced packaging as a growth driver.
StockAnalysis separately notes that Wells Fargo analyst Joe Quatrochi now carries an Overweight rating and has increased his Lam Research price target to 450 US dollars from 365 US dollars, reflecting confidence in the sustained upturn in wafer fab equipment demand tied to AI and advanced memory and logic investment cycles. Wells Fargo target change as reported by StockAnalysis On TrendSpider, roughly 84 percent of covering analysts are categorized as rating the shares a Buy, reinforcing the positive consensus backdrop around the NASDAQ-listed name. TrendSpider analyst sentiment snapshot
All news and data on the Lam Research shares
Charts, filings and previous headlines give additional context on the strong run in Lam Research and how analysts are positioning around the stock.
How Lam Research makes its money
Lam Research generates most of its revenue from selling wafer-fabrication equipment used in front-end semiconductor manufacturing, particularly etch and deposition tools that help form transistor structures and interconnect layers in advanced logic and memory chips. Company profile overview at FinancialData The company also provides spares, process kits and services under long-term agreements with key foundry and memory customers, creating a recurring revenue component alongside equipment cycles.
Where the shares trade today
Lam Research shares (US5324571083) most recently traded on NASDAQ at around 396.30 US dollars as of 2026-06-22, 10:43 Eastern Time, according to real-time quote data from FinancialData. FinancialData intraday quote and time stamp That level leaves the stock slightly below the 401.03 US dollar record print, but still near the top of its 52-week range.
Lam Research at a glance
- Company: Lam Research Corporation
- ISIN: US5324571083
- WKN: 869686
- Ticker: LRCX
- Trading venue: NASDAQ
- Price (as of 2026-06-22, 10:43): 396.30 USD
- Market cap: 496.64 billion USD (as of 2026-06-22)
- Sector / industry: Semiconductor equipment & materials
- Index membership: S&P 500, NASDAQ-100
- Next earnings date: 2026-07-29
This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer to buy or sell securities. Investors should conduct their own research or consult a professional advisor before making investment decisions.
